4.6 Article

Lower beta cell yield from donor pancreases after controlled circulatory death prevented by shortening acirculatory warm ischemia time and by using IGL-1 cold preservation solution

Related references

Note: Only part of the references are listed.
Article Immunology

Optimizing Temperature and Oxygen Supports Long-term Culture of Human Islets

Hirotake Komatsu et al.

TRANSPLANTATION (2019)

Article Medicine, General & Internal

The Effects of Using Pancreases Obtained from Brain-Dead Donors for Clinical Islet Transplantation in Japan

Taihei Ito et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Article Cell & Tissue Engineering

Quantifying the Effects of Different Neutral Proteases on Human Islet Integrity

Heide Brandhorst et al.

CELL TRANSPLANTATION (2017)

Article Endocrinology & Metabolism

Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

Bernhard J. Hering et al.

DIABETES CARE (2016)

Review Immunology

Categories of Donation After Cardiocirculatory Death

O. Detry et al.

TRANSPLANTATION PROCEEDINGS (2012)

Article Surgery

Time to Cardiac Death After Withdrawal of Life-Sustaining Treatment in Potential Organ Donors

C. Suntharalingam et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2009)

Article Endocrinology & Metabolism

Restoring a functional β-cell mass in diabetes

D. Pipeleers et al.

DIABETES OBESITY & METABOLISM (2008)

Article Surgery

Human islets derived from donors after cardiac death are fully biofunctional

M. Zhao et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2007)

Article Multidisciplinary Sciences

Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft

Bart Keymeulen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Pharmacology & Pharmacy

Polyethylene glycol reduces early and long-term cold ischemia-reperfusion and renal medulla injury

JP Faure et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)